Regulatory Approval Delays: Lifeward's success heavily depends on obtaining and maintaining necessary regulatory approvals for its products and services, which can be subject to lengthy processes, unexpected requirements, or outright rejections by health authorities.

Clinical Trial Failures: The development of new therapies or devices often involves extensive clinical trials. Failures in these trials, or unexpected adverse events, could lead to significant financial losses, reputational damage, and delays in product commercialization.

Intellectual Property Challenges: Lifeward's competitive advantage relies on its intellectual property. Risks include patent expiration, challenges to patent validity, infringement by competitors, or the inability to adequately protect proprietary technology, leading to erosion of market share.